Detalhe da pesquisa
1.
Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement.
Rheumatology (Oxford)
; 2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38335930